OXFORD, UK / ACCESSWIRE / September 12, 2023 / GENinCode Plc (AIM - GENI), the polygenics company focused on the prevention of cardiovascular disease, announced the presentation by Kaiser Permanente ...
Cardiovascular disease (“CVD”) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD. CVD accounts for one in every three deaths in the US, or more than ...
US Study Publication in the American Journal of Preventive Cardiology OXFORD, UK / ACCESSWIRE / April 5, 2024 / GENinCode Plc (www.genincode.com) the polygenics company focused on the prevention of ...
IRVINE, US, August 29, 2024 /EINPresswire.com/ -- GENinCode US Inc, the polygenics company focused on the prevention of cardiovascular disease and ovarian cancer ...
Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention IRVINE, CA / ACCESSWIRE / December 11, 2024 / GENinCode U.S., the ...
CARDIO inCode® publication in International Journal of Cardiology Cardiovascular Risk and Prevention
Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention IRVINE, CA, UNITED STATES, December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results